Inify Laboratories
Less than 1K followers
INIFY
Euronext Growth Oslo
Medical Equipment & Services
Health Care
Overview
Investor consensus
Inify Laboratories provides cancer diagnostics through pathology laboratory services. The company uses a digital, standardized workflow for response times and quality assurance, initially in prostate diagnostics. Customers primarily consist of laboratories and hospitals. Inify Laboratories was founded in 2022 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
-
Turnover
-
Revenue
24.05M
EBIT %
-316.54 %
P/E
-
Dividend yield-%
-
Financial calendar
29.4
2026
Interim report Q1'26
20.5
2026
General meeting '26
26.8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Inify Laboratories AB: Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics
Correction: Inify Laboratories - mandatory notification of trade
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools